Handling Inconsistency And Documenting The Record
Source: Life Science Leader
In this segment from the Life Science Leader Live event "FDA Engagement Strategies and Best Practices Amid Agency Changes," Jeremy Levin, Co-Founder and Executive Chairman, Ovid Therapeutics, explains how to tell a genuine policy inconsistency from an imagined one, and Annetta Beauregard details the meeting-minutes reconciliation process, and introduces BIO's new BRIDGE portal for anonymously reporting agency friction points.
Access The Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.
Subscribe to Life Science Leader
X
Subscribe to Life Science Leader